A Machine Learning Approach to Parkinson’s Disease Blood Transcriptomics
暂无分享,去创建一个
G. Pesole | G. Logroscino | N. Amoroso | A. Monaco | R. Bellotti | S. Tangaro | E. Picardi | A. Lombardi | B. Tafuri | L. Bellantuono | D. Urso | Claudio Lo Giudice | Salvatore Nigro | E. Pantaleo
[1] S. Papageorgiou,et al. Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review , 2022, Brain sciences.
[2] G. Pesole,et al. A primer on machine learning techniques for genomic applications , 2021, Computational and structural biotechnology journal.
[3] T. Sobrino,et al. Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets , 2021, Biomolecules.
[4] A. Adarmes-Gómez,et al. Peripheral Immune Profile and Neutrophil‐to‐Lymphocyte Ratio in Parkinson's Disease , 2021, Movement disorders : official journal of the Movement Disorder Society.
[5] Sayed Hadi Hashemi,et al. Multi-modality machine learning predicting Parkinson’s disease , 2021, npj Parkinson's Disease.
[6] A. Toga,et al. Quality Control Metrics for Whole Blood Transcriptome Analysis in the Parkinson's Progression Markers Initiative (PPMI) , 2021, medRxiv.
[7] Derek P. Narendra,et al. Mitochondrial Dysfunction and Mitophagy in Parkinson's Disease: From Mechanism to Therapy. , 2020, Trends in biochemical sciences.
[8] O. Rötzschke,et al. New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease , 2020, International journal of molecular sciences.
[9] Ester Pantaleo,et al. Identifying potential gene biomarkers for Parkinson’s disease through an information entropy based approach , 2020, Physical biology.
[10] I. Huijbers,et al. Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models , 2020, Scientific Reports.
[11] Fei Wang,et al. Mining genetic and transcriptomic data using machine learning approaches in Parkinson’s disease , 2020, npj Parkinson's Disease.
[12] A. Sehirli,et al. The Role of the SLC Transporters Protein in the Neurodegenerative Disorders , 2020, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.
[13] P. Lewis,et al. Vesicular Dysfunction and the Pathogenesis of Parkinson’s Disease: Clues From Genetic Studies , 2020, Frontiers in Neuroscience.
[14] I. Jonassen,et al. Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition , 2019, bioRxiv.
[15] Feng Jiang,et al. Identification of potential diagnostic biomarkers for Parkinson's disease , 2019, FEBS open bio.
[16] N. Erekat. Apoptosis and its Role in Parkinson’s Disease , 2018, Parkinson’s Disease: Pathogenesis and Clinical Aspects.
[17] Haniye Sadat Sajadi,et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.
[18] Norbert Schuff,et al. The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort , 2018, Annals of clinical and translational neurology.
[19] Sabina Sonia Tangaro,et al. Complex networks reveal early MRI markers of Parkinson's disease , 2018, Medical Image Anal..
[20] Yong Cheng,et al. Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis , 2018, Front. Mol. Neurosci..
[21] B. Pakkenberg,et al. Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014 , 2018, Gut.
[22] Claire Duvallet,et al. Correcting for batch effects in case-control microbiome studies , 2018, bioRxiv.
[23] G. Deuschl,et al. Analysis of blood-based gene expression in idiopathic Parkinson disease , 2017, Neurology.
[24] M. Nalls,et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci , 2017, Nature Genetics.
[25] K. Chaudhuri,et al. Non-motor features of Parkinson disease , 2017, Nature Reviews Neuroscience.
[26] S. Mallal,et al. T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.
[27] S. Orozco-Suárez,et al. Transient glutathione depletion in the substantia nigra compacta is associated with neuroinflammation in rats , 2016, Neuroscience.
[28] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[29] Xuejing Yue,et al. Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies , 2016, Medicine.
[30] Nicola Pavese,et al. Age at onset and Parkinson disease phenotype , 2016, Neurology.
[31] Tianqi Chen,et al. XGBoost: A Scalable Tree Boosting System , 2016, KDD.
[32] D. di Bernardo,et al. Blood transcriptomics of drug-naïve sporadic Parkinson’s disease patients , 2015, BMC Genomics.
[33] Margaret Sutherland,et al. Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study , 2015, The Lancet Neurology.
[34] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[35] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[36] Hagai Bergman,et al. Long Non-Coding RNA and Alternative Splicing Modulations in Parkinson's Leukocytes Identified by RNA Sequencing , 2014, PLoS Comput. Biol..
[37] A. Papavassiliou,et al. Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease , 2014, NeuroMolecular Medicine.
[38] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[39] David S. Greenberg,et al. Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes , 2013, Front. Mol. Neurosci..
[40] Sundaram Suresh,et al. Parkinson's disease prediction using gene expression - A projection based learning meta-cognitive neural classifier approach , 2013, Expert Syst. Appl..
[41] Jun Chen,et al. The integral nuclear membrane protein nurim plays a role in the suppression of apoptosis. , 2012, Current molecular medicine.
[42] S. Mandel,et al. A molecular signature in blood identifies early Parkinson’s disease , 2012, Molecular Neurodegeneration.
[43] G. Paratcha,et al. The GTPase-activating protein Rap1GAP: A new player to modulate Ret signaling , 2011, Cell Research.
[44] P. Riederer,et al. Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson’s disease , 2010, Journal of Neural Transmission.
[45] J. Vance,et al. SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease , 2010, PloS one.
[46] J. Growdon,et al. Molecular markers of early Parkinson's disease based on gene expression in blood , 2007, Proceedings of the National Academy of Sciences.
[47] Charles M Perou,et al. Evaluating the comparability of gene expression in blood and brain , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[48] S. Mandel,et al. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes , 2004, Journal of Neural Transmission.
[49] Makoto Sawada,et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains , 2003, Acta Neuropathologica.
[50] L. Breiman. Random Forests , 2001, Machine Learning.
[51] G. Lenzi,et al. Increased expression of dopamine receptors on lymphocytes in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.
[52] Robert Hill,et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease , 1995, Annals of neurology.
[53] A. Chen-Plotkin,et al. Parkinson disease: Blood transcriptomics for Parkinson disease? , 2018, Nature Reviews Neurology.
[54] M. Toft,et al. Found in transcription: accurate Parkinson's disease classification in peripheral blood. , 2013, Journal of Parkinson's disease.
[55] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[56] Leo Breiman,et al. Bagging Predictors , 1996, Machine Learning.
[57] Ashley Harms. Inflammation in Parkinson's disease. , 2001, Advances in neurology.